Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects.

Abstract

When and how to publish birth defects research can be complex, especially in the context of drugs used in pregnancy. Such research frequently involves multiple stakeholders, including regulatory agencies. Researchers must balance the potential peril of an unnecessarily panicked populace versus the benefit of protecting the public's health.